Treximet patents upheld in U.S. court; Rep calls for hearings on big PBM merger;

@FiercePharma: Gilenya isn't worth the price, NICE says.  Story | Follow @FiercePharma  

> Pozen's patents on the migraine drug Treximet, marketed by GlaxoSmithKline, were upheld in court, blocking generics makers' attempts to sell their own versions until at least 2017. News

> U.S. Rep. John Conyers Jr., is asking for a House Judiciary committee hearing on the proposed $29 billion merger between Express Scripts and Medco Health Solutions. Story

> Nestle is reportedly eyeing the nutritions unit Pfizer has decided to sell or spin off. Item

> India's Dr Reddy's Laboratories is counting on growth in North America to drive sales in the current fiscal year. Article

> The World Health Organization is auditing three Nigerian pharma companies with an eye toward improving their operations enough to prequalify their products. Piece

Biotech News

@FierceBiotech: Dendreon releases death-eaters into biotech sector stocks. News | Follow @FierceBiotech  

@JohnCFierce: South Korea's AnC to open research/manufacturing center in Vermont, plans to hire hundreds. Item | Follow @JohnCFierce

@MaureenFierce: Feds descend on San Diego-based vaccine developer NexBio. Report | Follow @MaureenFierce

> Xconomy: Dendreon has only itself to blame for Provenge fiasco. Story

> Researchers wary as Republicans vow to end ESC support. Details

> Venture group building a $50M fund for new biotech investments. Report

> Pfizer taps UCSD for $50M drug discovery program. News

> Is FDA writing a recipe for the failure of biosimilars in the U.S.? More

> VT officials spotlight foreign financing role for stem cell facility. Article

Biotech IT News

> IOM: U.S. health record surveillance is needed. Report

> Google, Microsoft fight science-citation cyberwar online. Details

> Social network algorithm helps identify protein "communities." More

> "Systems biology" integrates all that's known about disease and humans. Story 

> CliniWorks says award-wining AccelFind finds better patients. News

> Bioclinica continues revenue growth streak. Article

Medical Device News

> U.K. official admits he discussed Porton-M3 battle. Details

> Boston Sci invests $37M in Irish facility. More

> Knees help propel Smith & Nephew to a good Q2. News

> QIAGEN completes second submission of U.S. companion diagnostic. Article

> Quidel gets CE mark for influenza assay. Report

> Medtronic gives Yale $2.5M grant to review Infuse. Story

And Finally... Women who carry a faulty copy of a gene called RAD51D have an almost one in 11 chance of ovarian cancer, scientists said. This marks the most significant ovarian cancer gene discovery in 10 years. Report

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.